Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04659200
Other study ID # 06122020
Secondary ID
Status Completed
Phase
First received
Last updated
Start date September 1, 2020
Est. completion date December 7, 2020

Study information

Verified date January 2021
Source Bezmialem Vakif University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

COVID-19 infection causes a hypersensitive immune reaction and widespread inflammation through cytokines in various organs of the body, especially the lungs. This cytokine-mediated widespread inflammation can also affect the thyroid gland, causing thyroiditis and impaired thyroid functions. The researchers evaluated thyroid function tests and thyroid autoantibodies in patients hospitalized for COVID-19 infection. Researchers excluded patients on intensive care therapy and patients with known thyroid disease. The researchers examined the relationship of thyroid hormones and thyroid autoantibodies to COVID-19 disease, white blood cells, neutrophil / lymphocyte ratio, c reactive protein, fibrinogen, procalcitonin, ferritin, and D-dimer stages in these patients. Researchers compared changes in thyroid hormones and autoantibodies in people without COVID-19 infection and without thyroid disease.


Description:

The coronavirus-2 (SARS-COV-2) virus, which can cause severe acute respiratory syndrome through droplet, has caused the global Coronavirus 19 (COVID-19) pandemic. COVID-19 infection can be asymptomatic as well as lead to severe illness and even death. This virus causes a hypersensitive immune reaction and varying degrees of widespread inflammation through cytokines in various organs of the body, mainly the lungs. Cytokine-mediated widespread inflammation caused by the virus may also affect the thyroid gland and thyrocytes, causing thyroiditis and impairment of thyroid functions. Thus, it may cause changes in thyroid hormones and thyroid autoantibodies. In study, the researchers found that in patients who were symptomatic with COVID-19 infection and who were hospitalized, thyroid function tests such as serum thyrotropin (TSH), free triiodothyronine (FT3), free thyroxine (FT4) and thyroid peroxidase antibodies (TPOAb), anti-thyroglobulin evaluated antibodies (TGAb). The investigators did not recruit patients in intensive care and patients with known thyroid disease. Researchers looked at the association of patients' thyroid hormones and thyroid autoantibodies with white blood cells, neutrophil / lymphocyte ratio, c reactive protein, fibrinogen, procalcitonin, ferritin, D-dimer from hospital archives. The researchers determined how the thyroid hormones and autoantibodies of patients with COVID-19 infection were compared with healthy individuals without COVID-19 infection and thyroid disease.


Recruitment information / eligibility

Status Completed
Enrollment 20
Est. completion date December 7, 2020
Est. primary completion date December 5, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 100 Years
Eligibility Inclusion Criteria: - To accept research. - Being over the age of 18. - COVID 19 test results to be positive. - Not taking thyroid disease medication before. - Receiving inpatient treatment in the COVID service in the hospital. Exclusion Criteria: - Not accepting research. - Be under the age of 18. - Negative COVID 19 test results for patients. - COVID patients treated as outpatient. - Thyroid disease in the healthy control group.

Study Design


Intervention

Diagnostic Test:
Venous blood was collected for biochemistry testing.
For the measurement of blood tests, 10 ml of blood samples were taken from the right forearm veins with a syringe.

Locations

Country Name City State
Turkey Sabahattin Destek Fatih Istanbul

Sponsors (1)

Lead Sponsor Collaborator
Bezmialem Vakif University

Country where clinical trial is conducted

Turkey, 

References & Publications (4)

Brancatella A, Ricci D, Viola N, Sgrò D, Santini F, Latrofa F. Subacute Thyroiditis After Sars-COV-2 Infection. J Clin Endocrinol Metab. 2020 Jul 1;105(7). pii: dgaa276. doi: 10.1210/clinem/dgaa276. — View Citation

Caron P. Thyroid disorders and SARS-CoV-2 infection: From pathophysiological mechanism to patient management. Ann Endocrinol (Paris). 2020 Oct;81(5):507-510. doi: 10.1016/j.ando.2020.09.001. Epub 2020 Sep 18. Review. — View Citation

Mattar SAM, Koh SJQ, Rama Chandran S, Cherng BPZ. Subacute thyroiditis associated with COVID-19. BMJ Case Rep. 2020 Aug 25;13(8). pii: e237336. doi: 10.1136/bcr-2020-237336. — View Citation

van Gerwen M, Alsen M, Little C, Barlow J, Naymagon L, Tremblay D, Sinclair CF, Genden E. Outcomes of Patients With Hypothyroidism and COVID-19: A Retrospective Cohort Study. Front Endocrinol (Lausanne). 2020 Aug 18;11:565. doi: 10.3389/fendo.2020.00565. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Comparison of thyroid stimulating hormone (TSH) between groups In the study, serum TSH results of the Covid patient group and non-Covid control groups were recorded and compared statistically. 90 days
Primary Comparison of free triiodothyronine (fT3) between groups In the study, serum fT3 results of the Covid patient group and non-Covid control groups were recorded and compared statistically. 90 days
Primary Comparison of free thyroxine (fT4) between groups In the study, serum fT4 results of the Covid patient group and non-Covid control groups were recorded and compared statistically. 90 days
Primary Comparison of anti-thyroid peroxidase (Anti-TPO) between groups In the study, serum anti-TPO results of the Covid patient group and non-Covid control groups were recorded and compared statistically. 90 days
Primary Comparison of anti-thyroglobulin (Anti-Tg) between groups In the study, serum anti-Tg results of the Covid patient group and non-Covid control groups were recorded and compared statistically. 90 days
Primary White blood cells (WBC) results of Covid 19 patient group In the study, serum WBC results were recorded in Covid 19 patient groups. 90 days
Primary Neutrophil / lymphocyte ratio (N/LO) results of Covid 19 patient group In the study, serum N/LO results were recorded in Covid 19 patient groups. 90 days
Primary C-reactive protein (CRP) results of Covid 19 patient group In the study, serum CRP results were recorded in Covid 19 patient groups. 90 days
Primary Fibrinogen results of Covid 19 patient group In the study, serum fibrinogen results were recorded in Covid 19 patient groups. 90 days
Primary Procalcitonin results of Covid 19 patient group In the study, serum procalcitonin results were recorded in Covid 19 patient groups. 90 days
Primary Ferritin results of Covid 19 patient group In the study, serum ferritin results were recorded in Covid 19 patient groups. 90 days
Primary D-dimer results of Covid 19 patient group In the study, serum D-dimer results were recorded in Covid 19 patient groups. 90 days
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04997551 - Double Blind Randomized Clinical Trial of Use of Colchicine Added to Standard Treatment in Hospitalized With Covid-19 Phase 3
Recruiting NCT04977024 - SARS-CoV-2 Vaccine (GEO-CM04S1) Versus mRNA SARS-COV-2 Vaccine in Patients With Blood Cancer Phase 2
Completed NCT05049226 - Third Dose Vaccination With AstraZeneca or Pfizer COVID-19 Vaccine Among Adults Received Sinovac COVID-19 Vaccine Phase 2
Completed NCT04666025 - SARS-CoV-2 Donor-Recipient Immunity Transfer
Terminated NCT04455815 - A Trial Looking at the Use of Camostat in People Who Have Tested Positive for Coronavirus (COVID-19) (SPIKE-1) Phase 2
Completed NCT04662437 - The Status of Parathyroid Hormone Secretion in Covid-19 Patients
Recruiting NCT05792878 - Study of COVID-19 Infection and Its Clinical Prognosis in Chronic Hepatitis B Patients With Antiviral Therapy
Recruiting NCT04470583 - Evaluating Clinical Parameters of COVID-19 in Pregnancy
Withdrawn NCT04377568 - Efficacy of Human Coronavirus-immune Convalescent Plasma for the Treatment of COVID-19 Disease in Hospitalized Children Phase 2
Completed NCT04848610 - The Factors That Affect the Infection of COVID-19
Recruiting NCT04582903 - Send-In Sample Collection for Comprehensive Analyses of Innate and Adaptive Immune Responses During Acute COVID-19 and Convalescence
Recruiting NCT06032000 - Evaluation of Safety and Immunogenicity of a SARS-CoV-2(Severe Acute Respiratory Syndrome Coronavirus 2) Booster Vaccine (LEM-mR203) Phase 1
Terminated NCT04941703 - "CHANGE COVID-19 Severity" Phase 1/Phase 2
Active, not recruiting NCT04639466 - A Synthetic MVA-based SARS-CoV-2 Vaccine, GEO-CM04S1, for the Prevention of COVID-19 Infection Phase 1/Phase 2
Completed NCT04575038 - CRISIS2: A Phase 2 Study of the Safety and Antiviral Activity of Brequinar in Non-hospitalized Pts With COVID-19 Phase 2
Recruiting NCT05022446 - The Impact of COVID-19 on Pulmonary Procedures
Completed NCT04347798 - IMPACT: IMPact of Antimalarials on Covid-19 Infections in RAPPORT
Active, not recruiting NCT04650178 - Well-being in Cancer Patients With Neuropathy During COVID-19 Who Participated in Prior Clinical Trials
Recruiting NCT04169542 - Impact of COVID-19 Pandemic on Out-of-Pocket Costs, Lost Wages, and Unemployment in Patients With Breast Cancer Undergoing Breast Surgery
Recruiting NCT04382781 - Immunosupressive Treatment in COVID-19 Patients